Given the importance of B23/NPM1 inhibition for the effect of CIGB-300 in solid tumors, we next investigated whether a similar mechanism could account for CIGB-300 anti-leukemia effects by silencing NPM1 in HPB-ALL cells. The gene discussed is NPM1; the disease is leukemia.